The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Cellular accumulation of the anticancer agent cisplatin: A review
Open accessAbstract
Acquired resistance to cisplatin (DDP) is a major clinical problem in the treatment of ovarian, testicular, and head and neck carcinomas; decreased accumulation of DDP is the most consistently observed alteration in resistant cells. It has been postulated that DDP enters the cell by passive diffusion based on the observations that DDP accumulation is proportional to the drug concentration, accumulation is not saturable, and that structural analogs of DDP do not inhibit accumulation. However, recent studies show that DDP accumulation can be specifically stimulated or inhibited by pharmacological agents and the activation of signal transduction pathways. This paper reviews the existing data on the mechanism of DDP accumulation and develops the postulate that some component of transport occurs through a gated ion channel.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance.
Andrews, P. A., & Howell, S. B. (1990) · PubMed · Cited by 397
Self-citationMann, S. C., Andrews, P. A., & Howell, S. B. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00684878 · Cited by 349
Self-citationModulation of cis-diamminedichloroplatinum(II) resistance: a review
Timmer-Bosscha, H., Mulder, N., & de Vries, E. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.249 · Cited by 164
Andrews, P. A., Jones, J. A., Varki, N. M., & Howell, S. B. (1990) · Cancer Communications · doi:10.3727/095535490820874641 · Cited by 130
Self-citationMann, S. C., Andrews, P. A., & Howell, S. B. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480613 · Cited by 95
Self-citationBasu, A., Teicher, B. A., & Lazo, J. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38909-4 · Cited by 92
Kinetics and mechanism of uptake of platinum-based pharmaceuticals by the rat small intestine
Binks, S. P., & Dobrota, M. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90400-f · Cited by 91
Isonishi, S., Andrews, P. A., & Howell, S. B. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39638-3 · Cited by 86
Self-citationKawai, K., Kamatani, N., Georges, E., & Ling, V. W. T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38277-8 · Cited by 85
Decreased cisplatin uptake by resistant L1210 leukemia cells
Hromas, R., North, J. A., & Burns, C. P. (1987) · Cancer Letters · doi:10.1016/0304-3835(87)90091-7 · Cited by 65
Timmer‐Bosscha, H., Hospers, G. A. P., Meijer, C., Mulder, N. H., Muskiet, F. A. J., Martini, I. A., Uges, D. R. A., & de Vries, E. G. E. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.14.1069 · Cited by 63
Kikuchi, Y., Iwano, I., Miyauchi, M., Sasa, H., Nagata, I., & Kuki, E. (1990) · Gynecologic Oncology · doi:10.1016/0090-8258(90)90432-k · Cited by 33
Ogawa, M., Gale, G. R., & Keirn, S. S. (1975) · PubMed · Cited by 29
Melvik, J. E., & Pettersen, E. O. (1988) · Radiation Research · doi:10.2307/3577120 · Cited by 17
Cited by
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,485
Metadata
- Authors
- Gately, D., & Howell, S.
- Venue
- British Journal of Cancer
- Published
- 1993-06
- Volume
- 67
- Issue
- 6
- Pages
- 1171-1176
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2078144803
- Cited by
- 572
- References
- 14
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.